Published date: 22 December 2016

Last edited date: 22 December 2016

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 19 January 2016

Contract summary

Industry

  • General anti-infectives for systemic use and vaccines - 33651000

Location of contract

Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£0

Procurement reference

CM/PHV/12/5351/2

Published date

22 December 2016

Closing date

19 January 2016

Contract start date

1 July 2016

Contract end date

30 June 2018

Contract type

Supply contract

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The provision of a vaccine to prevent highgrade cervical intraepithelial neoplasia (CIN grades 2 and 3) and cervical cancer causally related to Human Papillomavirus types 16 and 18, to be used in the national immunisation programme, and deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.

More information

Attachments

Award information

Awarded date

13 April 2016

Contract start date

1 July 2016

Contract end date

30 June 2018

Total value of contract

£0

This contract was awarded to 1 supplier.

Sanofi Pasteur MSD Ltd

Address

Mallards Reach
Bridge Avenue
Maidenhead

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

Additional details

This supplier is not an SME

About the buyer

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

natalie.howell@dh.gsi.gov.uk